stars 1 stars 2 stars 3

At SignatureDx, we are spearheading research in advanced diagnostics to develop novel methods for the early detection and treatment of complex human disease. Early diagnosis of complex human disease gives individuals the best chance for successful treatment. When care is delayed or inaccessible there is a lower quality of treatment, greater problems associated with treatment and higher costs of care. Early diagnosis improves patient outcomes by providing care at the earliest possible stage. SignatureDx is changing the paradigm of healthcare intervention by developing noninvasive methods to detect and monitor silently progressing complex human disease through our revolutionary bioanalytical platform.

SignatureDx Questions

Dave Colaizzi is the Co-Founder, CEO of SignatureDx.

14 people are employed at SignatureDx.

SignatureDx is based in Pittsburgh, Pennsylvania.

Top SignatureDx Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users